# A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

> **NCT06809400** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 127 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** LY4006896
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06809400
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-18
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 127 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06809400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06809400, "A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT06809400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*